Table 5 Data from polygraphy- or oximetry-based ASV quality monitoring performed in the last 6 months preceding the inclusion in the study
|  | N | Whole group N = 177 | CSA group N = 105 | OSA group N = 36 | TECSA group N = 36 | P |
|---|---|---|---|---|---|---|
Polygraphy, n (%) | 173 | 31 (17.9%) | 18 (17.5%) | 7 (20.6%) | 6 (16.7%) | 0.897 |
Apnea Hypopnea Index, (n/h) | 31 | 1.90 [0.4;4.2] | 1.50 [0.4;2.4] | 3.5 [0.4;21.9] | 1.55 [0.2;4.2] | 0.578 |
Apnea Index, (n/h) | 31 | 0.0 [0.0;0.2] | 0.0 [0.0;0.2] | 0.10 [0.00;2.70] | 0.0 [0.0;0.2] | 0.369 |
Hypopnea Index, (n/h) | 31 | 1.9 [0.4;3.9] | 1.3 [0.4;2.4] | 3.5 [0.2;11.8] | 1.5 [0.9;3.9] | 0.659 |
ODI 3%, (n/h) | 30 | 6.9 [3.9;11.6] | 4.7 [2.4;7.2] | 9.1 [7.5;23.9] | 11.3 [4.5;19.9] | 0.056 |
Mean SpO2, (%) | 30 | 95.2 [94.0;96.0] | 95.5 [94.8;96.0] | 95.0 [93.0;95.9] | 94.0 [92.70;96.0] | 0.379 |
Modification of ASV settings as a consequence of polygraphy, n (%) | 31 | 7 (22.6%) | 2 (11.1%) | 3 (42.9%) | 2 (33.3%) | 0.138 |
Oximetry, n (%) | 160 | 24 (15.0%) | 17 (17.9%) | 4 (11.8%) | 3 (9.7%) | 0.531 |
ODI (n/h) | 24 | 3.2 [1.5;9.7] | 2.8 [1.9;10.9] | 3.5 [2.1;5.8] | 8.7 [1.1;10.7] | 0.908 |
Mean SpO2, (%) | 24 | 93.5 [92.0;94.0] | 93.1 [91.4;94.0] | 94.0 [93.0;96.0] | 93.6 [93.0;93.6] | 0.478 |
Modification of ASV settings as a consequence of oximetry, n (%) | 24 | 7 (29.2%) | 6 (35.3%) | 0 (0%) | 1 (33.33%) | 0.519 |